Skip to main content
. 2022 Nov 30;2022:6786351. doi: 10.1155/2022/6786351

Table 2.

Comparison of serum LAPTM4B levels in breast cancer patients and normal controls (median (IQR)).

Group Number LAPTM4B (ng/mL) p value
Controls 80 2.01 (2.36) p < 0.001
BC (stage I + II) 250 8.85 (15.40)
BC (stage III + IV) 176 13.91 (35.33)